Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1999
10/14/1999WO1999051727A2 Human nucleic acid sequences of normal ovary tissue
10/14/1999WO1999051723A2 Bacterial transglutaminases
10/14/1999WO1999051642A1 Antibody variants and fragments thereof
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051639A1 An integrin heterodimer and a subunit thereof
10/14/1999WO1999051630A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999WO1999051266A2 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999WO1999051258A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
10/14/1999WO1999051255A1 Telomerase-associated proteins
10/14/1999WO1999051253A2 Immune response modulation
10/14/1999WO1999051188A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999051186A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999051185A2 Human galactosyl transferases
10/14/1999WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999042075A3 Antibodies against human cd40
10/14/1999WO1999040189A3 Cdnas encoding secreted proteins
10/14/1999WO1999039729A3 Use of heregulin as an epithelial cell growth factor
10/14/1999WO1999037803A3 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
10/14/1999WO1999037681A3 Method for producing antibody fragments
10/14/1999WO1999036544A3 Neisseria meningitidis antigens
10/14/1999WO1999036094A9 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen
10/14/1999WO1999031225A3 Human phosphatases
10/14/1999WO1999028462A3 Polypeptides and nucleic acids encoding the same
10/14/1999DE19816141A1 New polyspecific binding agents containing variable heavy and light constructs connected via peptide linker, used for treatment, prevention or diagnosis of e.g. cancer
10/14/1999CA2740948A1 Antibody variants and fragments thereof
10/14/1999CA2577543A1 Antibody variants and fragments thereof
10/14/1999CA2328294A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999CA2327652A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999CA2326388A1 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999CA2326066A1 A interleukin-1 receptor antagonist and uses thereof
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325346A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
10/14/1999CA2325340A1 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325016A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999CA2325007A1 Human galactosyl transferases
10/14/1999CA2324868A1 Human oxidized ldl receptor
10/14/1999CA2324381A1 An integrin heterodimer and a subunit thereof
10/13/1999EP0949332A2 HSSCRG1 polypeptides
10/13/1999EP0949271A1 Novel dna, novel protein, and novel antibody
10/13/1999EP0948630A2 Cloning and characterization of napsin, an aspartic protease
10/13/1999EP0948625A2 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS)
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948621A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
10/13/1999EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
10/13/1999EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948544A1 Monovalent antibody fragments
10/13/1999EP0948543A1 Hvem polypeptides and uses thereof
10/13/1999EP0948542A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/13/1999EP0948533A1 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES
10/13/1999EP0948531A1 Secreted human proteins
10/13/1999EP0948530A2 Mammalian cell surface antigens; related reagents
10/13/1999EP0948528A2 $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999EP0948516A1 Method for determining expression of aberrant forms of apc protein
10/13/1999EP0948515A1 Human b-cell translocation genes-2 and 3
10/13/1999EP0948508A1 Novel coding sequences from herpes simplex virus type-2
10/13/1999EP0948360A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
10/13/1999EP0948356A1 Agent for identifying and treating metastasizing tumours
10/13/1999EP0948355A1 Treatment of lupus nephritis with anti-cd40l compounds
10/13/1999EP0948354A1 Calcium-independent modulation by cd81 of receptor signalling
10/13/1999EP0948353A1 Methods and compositions for immunomodulation
10/13/1999EP0948344A1 Synthetic antibiotics
10/13/1999EP0793502A4 Novel hedgehog-derived polypeptides
10/13/1999EP0770088A4 Novel cytokine designated lerk-5
10/13/1999EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999EP0603307B1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same
10/13/1999EP0567575B1 Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof
10/13/1999EP0564592B1 Liver enriched transcription factor
10/13/1999CN1045621C Process for preparing immunoglobulin conjugates
10/12/1999US5965713 Dye labeled protein conjugate its preparing method and sensor using the same
10/12/1999US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999US5965710 An immunoglobulin which binds human membrane-bound carcinoembryonic antigen; anticarcinogenic agent
10/12/1999US5965709 Mutant immunoglobulin e binding determinant sequences in the fc epsilon domain; antiallergens
10/12/1999US5965704 Class two cytokine receptor-11
10/12/1999US5965535 Isolated human leukocyte antigen (hla) class ii-binding peptide and amino sequence encoding it; the peptides stimulate the activity and proliferation of cd4+ t lymphocytes
10/12/1999US5965523 Promoting angiogenesis by administering scatter factor
10/12/1999US5965455 Ryegrass pollen allergen
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965419 Purified sulfotransferase
10/12/1999US5965417 Arabidepsi thaliana proteins having Δ-5,7-sterol-Δ-7-reductase activity
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965405 Making recombinant antibodies containing the light and heavychain variable domains by transforming cells with an operon having a dna sequence which codes for only the variable domains, culturing and collecting expressed protein
10/12/1999US5965403 Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
10/12/1999US5965402 DNA encoding phoH polypeptides
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965392 A nucleic acid molecule; treating obesity or anorexia
10/12/1999US5965390 Protein L and hybrid proteins thereof
10/12/1999US5965382 Nucleic acid encoding secreted Mac-2 binding glycoprotein
10/12/1999US5965378 Antibodies and/or antibody fragments which bind fd section of heavy chain of at least one class of immunoglobulins g, a, d, e and partially suppress binding of immunoglobulins to antigen; for pretreatment of immunoassay samples
10/12/1999US5965376 Evaluating cytotoxic compounds by exposing cells to test compound, measuring amount of fluid-soluble interior nuclear matrix protein released, comparing amount to standard; anticarcinogenic/antitumor/antiischemic/antihypoxic agents
10/12/1999US5965374 Glucan-specific assay
10/12/1999US5965371 Targeting undesired antigens by intracellular expression of antibody capable of binding to the target; delivering a dna sequence with a promoter operably linked to the antibody; expressing antibody and binding antigen in cells of interest
10/12/1999US5965367 Purified bradykinin B1 receptor
10/12/1999US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents
10/12/1999US5965360 Diagnosis of metastatic cancer by the mts-1 gene
1 ... 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 ... 1494